Moneycontrol PRO
LAMF
LAMF

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy Glenmark Pharma, target Rs 1100: Chandan Taparia

  • Look at Dr Reddy's Lab, Sun Pharma: Prakash Diwan

  • Super Six chart picks for September 15

  • Wockhardt traders pick, may test Rs 1550: Hemant Thukral

  • Buy pharma stocks, says Sudarshan Sukhani

  • Bull's Eye: Buy UPL, Eros, Dish TV, sell Ceat, Sun TV, BEL

  • HDFC Bank, Infosys top picks; like L&T, IOC: R Sreeshankar

  • Top buzzing midcap stocks to trade on September 10

  • Buy Glenmark Pharma, target Rs 1120: Manav Chopra

  • Is it the right time to enter pharma stocks?

  • Bull's Eye: Sell Wockhardt, Asian Paints, buy SKS Micro

  • Glenmark Pharma top pick, says Prakash Diwan

  • Bull's Eye:Sell NMDC, DLF, REC, IRB Infra, Ceat, Amara Raja

  • Like Glenmark, Mindtree, Persistent Systems: R Sreesankar

  • Buy Glenmark Pharma, advises Sudarshan Sukhani

  • Bull's Eye: Buy LIC Housing, Just Dial, JSPL, Canara Bank

  • Pharmaceutical stocks buying opportunity: Sudarshan Sukhani

  • Glenmark Pharma can head higher, target Rs 1253: Rajat Bose

  • Buy Lupin, Glenmark Pharma on dips: Sudarshan Sukhani

  • Like Divis Laboratories, Torrent Pharma: Anmol Ganjoo

  • Top buzzing midcap stocks to trade on August 19

  • Glenmark Pharma top pick, like Ipca Lab: Sudip Bandopadhyay

  • Buy TCS, Glenmark Pharma: Yogesh Mehta

  • Buy Glenmark Pharma, target Rs 1200: Chandan Taparia

  • Prefer IT, pharma space: Pashupati Advani

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347